Domenico D'Amario, MD, PhD

Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry

Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry

12/01/2020

Vincenzo De Marzo , MD;

Marco Caruso , MD;

Domenico D'Amario , MD, PhD;

Gianmarco Annibali , MD;

Vincenzo Manganiello , MD;

Rocco Vergallo , MD, PhD;

Michael Donahue , MD;

Pio Cialdella , MD;

Alfonso Ielasi , MD;

Leonardo Misuraca , MD;

Bernardo Cortese , MD;

Luca Altamura , MD;

Italo Porto , MD, PhD;

Claudio Larosa , MD;

Rosario Parisi , MD;

Marco Canepa , MD, PhD;

Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...

Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...

Our objective was to evaluate...

12/01/2020

Journal of Invasive Cardiology

Original Contribution

Feasibility and Safety of Right and Left Heart Catheterization Via an Antecubital Fossa Vein and the Radial Artery in Patients With Heart Failure

06/15/2017

Giampaolo Niccoli , MD, PhD;

Carlo Trani , MD;

Italo Porto , MD, PhD;

Cristina Aurigemma , MD, PhD;

Filippo Crea , MD;

Aureliano Ruggio , MD;

Josip A. Borovac , MD, PhD;

Massimo Massetti , MD;

Antonio Maria Leone , MD, PhD;

Domenico D'Amario , MD, PhD;

To determine the feasibility and safety of full arm-arm catheterization access, we aimed to compare this approach with other established catheterization approaches.

To determine the feasibility and safety of full arm-arm catheterization access, we aimed to compare this approach with other established catheterization approaches.

To determine the feasibility and...

06/15/2017

Journal of Invasive Cardiology

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar